VHL - Von Hippel-Lindau Syndrome
·MeSH: von Hippel-Lindau Disease
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Belzutifan | Merck & Co., Inc. (MRK) |
Frequently asked questions
How many drugs are in development for VHL - Von Hippel-Lindau Syndrome?
BioSniper tracks 1 drug in development for VHL - Von Hippel-Lindau Syndrome across 1 company.
How many clinical trials target VHL - Von Hippel-Lindau Syndrome?
There are 1 clinical trial targeting VHL - Von Hippel-Lindau Syndrome tracked by BioSniper.
Deep-dive into VHL - Von Hippel-Lindau Syndrome
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis